Inflammatory Biomarkers Interleukin‐6 and C‐Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial-Reference-Cited by-同舟云学术

Inflammatory Biomarkers Interleukin‐6 and C‐Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial

Published:2017-10-11 Issue:10 Volume:6 Page:
ISSN:2047-9980
Container-title:Journal of the American Heart Association
language:en
Short-container-title:JAHA

Author:

Held Claes¹²,White Harvey D.³,Stewart Ralph A. H.³,Budaj Andrzej⁴,Cannon Christopher P.⁵,Hochman Judith S.⁶,Koenig Wolfgang⁷⁸⁹,Siegbahn Agneta²¹⁰,Steg Philippe Gabriel¹¹¹²¹³¹⁴,Soffer Joseph¹⁵,Weaver W. Douglas¹⁶,Östlund Ollie²,Wallentin Lars¹²,

Affiliation:

1. Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden

2. Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden

3. Green Lane Cardiovascular Service, Auckland City Hospital, Auckland, New Zealand

4. Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland

5. Cardiovascular Division, Brigham and Women's Hospital, Boston, MA

6. Department of Medicine, NYU Langone Medical Center, New York, NY

7. Department of Internal Medicine II‐Cardiology, University of Ulm Medical Center, Ulm, Germany

8. Deutsches Herzzentrum München, Technische Universität München, Munich, Germany

9. DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany

10. Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden

11. Département Hospitalo‐Universitaire FIRE, AP‐HP, Hôpital Bichat, Paris, France

12. Paris Diderot University Sorbonne Paris Cité, Paris, France

13. NHLI Imperial College, ICMS, Royal Brompton Hospital, London, United Kingdom

14. FACT (French Alliance for Cardiovascular Trials), an F‐CRIN network, INSERM U1148, Paris, France

15. Metabolic Pathways and Cardiovascular Therapeutic Area, GlaxoSmithKline, Collegeville, PA

16. Henry Ford Heart and Vascular Institute, Detroit, MI

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference24 articles.

1. Inflammation in Atherosclerosis

2. Inflammation and Atherosclerosis

3. Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis

4. C-Reactive Protein and Other Circulating Markers of Inflammation in the Prediction of Coronary Heart Disease

5. Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men

Cited by 205 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the therapeutic potential of interleukin-6 receptor blockade in cardiovascular disease treatment through Mendelian randomization;Scientific Reports;2024-09-13

2. TAX1BP1/A20 inhibited TLR2-NF-κB activation to induce tolerant expression of IL-6 in endothelial cells;International Immunopharmacology;2024-09

3. La phospholipase A2 associée aux lipoprotéines (Lp-PLA2) : biomarqueur pertinent et cible thérapeutique ?;Annales Pharmaceutiques Françaises;2024-09

4. First time ACS in patients with on‐target lipid levels: Inflammation at admission and re‐event rate at follow‐up;European Journal of Clinical Investigation;2024-08-19

5. Causal relationship of inflammatory cytokines and serum metabolites in cerebral small vessel disease: a two‐step Mendelian randomization study;European Journal of Neurology;2024-08-16